CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Sell
41
MSEX Quote, Financials, Valuation and Earnings
Last price:
$60.58
Seasonality move
:
4.68%
Day range:
$59.61 - $62.07
52-week range:
$48.18 - $70.73
Dividend yield:
2.17%
P/E ratio:
25.38x
P/S ratio:
5.61x
P/B ratio:
2.44x
Volume:
117K
Avg. volume:
181.2K
1-year change:
13.68%
Market cap:
$1.1B
Revenue:
$191.9M
EPS (TTM):
$2.41
Analysts' Opinion
-
Consensus RatingMiddlesex Water has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $66.33, Middlesex Water has an estimated upside of 8.44% from its current price of $61.17.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $60.00 representing 1.91% downside risk from its current price of $61.17.
Fair Value
-
According to the consensus of 2 analysts, Middlesex Water has 8.44% upside to fair value with a price target of $66.33 per share.
MSEX vs. S&P 500
-
Over the past 5 trading days, Middlesex Water has underperformed the S&P 500 by -2.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Middlesex Water does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Middlesex Water has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Middlesex Water reported revenues of $44.3M.
Earnings Growth
-
Middlesex Water earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Middlesex Water reported earnings per share of $0.53.
Enterprise value:
1.5B
EV / Invested capital:
1.76x
Price / LTM sales:
5.61x
EV / EBIT:
23.78x
EV / Revenue:
7.61x
PEG ratio (5yr expected):
1.31x
EV / Free cash flow:
-112.02x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
16.08x
Gross Profit (TTM):
$102.6M
Return On Assets:
3.43%
Net Income Margin (TTM):
22.05%
Return On Equity:
9.78%
Return On Invested Capital:
5.11%
Operating Margin:
26.09%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $164.4M | $168.6M | $195.7M | $40.5M | $44.3M | |
| Gross Profit | $84.2M | $85.3M | $102.6M | $20.1M | $23.2M | |
| Operating Income | $42.3M | $41.6M | $54.9M | $9.9M | $11.6M | |
| EBITDA | $75.9M | $79.2M | $92.6M | $21.2M | $21.3M | |
| Diluted EPS | $2.03 | $2.02 | $2.41 | $0.59 | $0.53 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $31.4M | $32.9M | $39.5M | $111.2M | $46.5M | |
| Total Assets | $986.2M | $1B | $1.1B | $1.3B | $1.3B | |
| Current Liabilities | $65.8M | $59.7M | $96M | $117.2M | $101.2M | |
| Total Liabilities | $635.3M | $629.6M | $693.5M | $820.3M | $828.3M | |
| Total Equity | $350.9M | $380M | $405.4M | $429.8M | $450.7M | |
| Total Debt | $292.8M | $328.2M | $375.6M | $422.8M | $393M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $63.4M | $43.5M | $65.9M | $6.7M | $13.8M | |
| Cash From Investing | -$99.2M | -$80.1M | -$79.1M | -$14.4M | -$18.9M | |
| Cash From Financing | $37.4M | $34.6M | $13.1M | $8.2M | $3.6M | |
| Free Cash Flow | -$35.9M | -$36.6M | -$13.3M | -$7.7M | -$5.1M | |
MSEX
Sector
Market Cap
$1.1B
$3.8B
Price % of 52-Week High
86.48%
87.75%
Dividend Yield
2.17%
3.12%
Shareholder Yield
2.27%
0.89%
1-Year Price Total Return
13.68%
1.27%
Beta (5-Year)
0.884
0.470
Dividend yield:
2.17%
Annualized payout:
$1.32
Payout ratio:
55.28%
Growth streak:
21 years
Technicals
8-day SMA
Sell
Level
$61.64
200-day SMA
Buy
Level
$60.38
Bollinger Bands (100)
Buy
Level
51.26 - 62.08
Chaikin Money Flow
Buy
Level
11.7M
20-day SMA
Sell
Level
$61.96
Relative Strength Index (RSI14)
Sell
Level
48.02
ADX Line
Sell
Level
22
Williams %R
Neutral
Level
-41.0477
50-day SMA
Buy
Level
$60.78
MACD (12, 26)
Buy
Level
0.08
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
12.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2029)
Sell
CA Score
(Annual)
Level (-0.8622)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.2157)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
Stock Forecast FAQ
In the current month, MSEX has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MSEX average analyst price target in the past 3 months is $66.33.
-
Where Will Middlesex Water Stock Be In 1 Year?
According to analysts, the consensus estimate is that Middlesex Water share price will rise to $66.33 per share over the next 12 months.
-
What Do Analysts Say About Middlesex Water?
Analysts are divided on their view about Middlesex Water share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Middlesex Water is a Sell and believe this share price will drop from its current level to $60.00.
-
What Is Middlesex Water's Price Target?
The price target for Middlesex Water over the next 1-year time period is forecast to be $66.33 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is MSEX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Middlesex Water is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of MSEX?
You can purchase shares of Middlesex Water via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Middlesex Water shares.
-
What Is The Middlesex Water Share Price Today?
Middlesex Water was last trading at $60.58 per share. This represents the most recent stock quote for Middlesex Water. Yesterday, Middlesex Water closed at $61.17 per share.
-
How To Buy Middlesex Water Stock Online?
In order to purchase Middlesex Water stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
